Moreover, this finding suggests a mechanistic basis for the regulation of autophagy and apoptosis by activation of FXR, which may be a potential pharmacological target in the early stages of kidney damage and as a therapy when AKI progresses to CKD. This evidence concerns the gene NR1H4 and Nephropathy.